Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2002 1
2004 1
2009 1
2012 2
2013 2
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Your search for Components of the metabolic syndrome-risk factors for teh development of benign prostatic hyperplasia retrieved no results
Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.
Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, Maggi M. Corona G, et al. Int J Endocrinol. 2014;2014:329456. doi: 10.1155/2014/329456. Epub 2014 Feb 13. Int J Endocrinol. 2014. PMID: 24688539 Free PMC article. Review.
Metabolic syndrome (MetS) is a well-recognized cluster of cardiovascular (CV) risk factors including obesity, hypertension, dyslipidemia, and hyperglycaemia, closely associated with an increased risk of forthcoming cardiovascular disease and typ …
Metabolic syndrome (MetS) is a well-recognized cluster of cardiovascular (CV) risk factors including obesity, hy …
Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.
Hammarsten J, Högstedt B, Holthuis N, Mellström D. Hammarsten J, et al. Prostate Cancer Prostatic Dis. 1998 Mar;1(3):157-162. doi: 10.1038/sj.pcan.4500221. Prostate Cancer Prostatic Dis. 1998. PMID: 12496910
The purpose of the present study was to perform a BPH risk factor analysis in men, relating the prostate gland volume to components of the metabolic syndrome and to identify clues to the etiology of BPH. ...On the basis of our findings, we concluded th …
The purpose of the present study was to perform a BPH risk factor analysis in men, relating the prostate gland volume to component …
The impact of metabolic syndrome on the responsiveness to alpha1-blocker in men with BPH/LUTS.
Lee YC, Liu CC, Juan YS, Wu WJ, Li WM, Yeh HC, Wang CJ, Huang CN, Huang CH, Huang SP. Lee YC, et al. Int J Clin Pract. 2013 Apr;67(4):356-62. doi: 10.1111/ijcp.12086. Epub 2013 Feb 14. Int J Clin Pract. 2013. PMID: 23409734
AIMS: Increasing evidence has proposed the components of metabolic syndrome (MtS) as risk factors for the development of benign prostate hyperplasia (BPH); therefore, it is thought that MtS may play a role in lower urinary t …
AIMS: Increasing evidence has proposed the components of metabolic syndrome (MtS) as risk factors for the …
Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
Lee SH, Kim JC, Lee JY, Kim JH, Oh CY, Lee SW, Yoo SJ, Chung BH. Lee SH, et al. J Sex Med. 2009 Aug;6(8):2292-8. doi: 10.1111/j.1743-6109.2009.01325.x. Epub 2009 Jun 2. J Sex Med. 2009. PMID: 19493291
INTRODUCTION: There are limited data concerning the association between components of metabolic syndrome and sexual function in men aged 40 years and older in Korean benign prostatic hyperplasia (BPH) patients. AIM: To examine the effects …
INTRODUCTION: There are limited data concerning the association between components of metabolic syndrome and sexual fun …
Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
Hammarsten J, Högstedt B. Hammarsten J, et al. Eur Urol. 2001 Feb;39(2):151-8. doi: 10.1159/000052430. Eur Urol. 2001. PMID: 11223674
To test the hypothesis of hyperinsulinaemia as a causal factor for the development of benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: Three hundred and seven consecutive patients with lower urinary tract symptoms were studied. A subgroup of 1 …
To test the hypothesis of hyperinsulinaemia as a causal factor for the development of benign prostatic hyperplasia …
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827. Scand J Urol Nephrol. 2002. PMID: 12487736
OBJECTIVE: Whether there is an association between the development of benign prostatic hyperplasia (BPH) and clinical prostate cancer is controversial. ...The study generates the hypothesis that clinical prostate cancer is a component of the …
OBJECTIVE: Whether there is an association between the development of benign prostatic hyperplasia (BPH) and cli …
Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
Hammarsten J, Högstedt B. Hammarsten J, et al. Blood Press. 1999;8(1):29-36. doi: 10.1080/080370599438365. Blood Press. 1999. PMID: 10412880
The present study was designed as a risk factor analysis of BPH in which the estimated annual BPH growth rate was related to components of the metabolic syndrome. ...In conclusion, the data suggest that NIDDM, hypertension, tallness, obesity, hi …
The present study was designed as a risk factor analysis of BPH in which the estimated annual BPH growth rate was related to …
Metabolic Syndrome and Lower Urinary Tract Symptoms: Epidemiological Study.
Yoon H. Yoon H. Low Urin Tract Symptoms. 2012 Mar;4 Suppl 1:2-7. doi: 10.1111/j.1757-5672.2011.00119.x. Low Urin Tract Symptoms. 2012. PMID: 26676692
Multiple studies have demonstrated strong independent associations between LUTS and components of metabolic syndrome. Therefore, modification of lifestyle factors may lower the risk of LUTS. Prevalence of MS is age-dependent with gender differen …
Multiple studies have demonstrated strong independent associations between LUTS and components of metabolic syndrome. T …
Association between Metabolic Syndrome and Lower Urinary Tract Symptoms: Evidences from Epidemiological Studies.
Tai HC, Yu HJ. Tai HC, et al. Low Urin Tract Symptoms. 2012 Mar;4 Suppl 1:8-10. doi: 10.1111/j.1757-5672.2011.00123.x. Low Urin Tract Symptoms. 2012. PMID: 26676693
The relationship between MS and LUTS was first described by Hammarsten et al. and concluded that men with MS risk factors had a larger prostate volume and a faster growth rate. Several consequent studies have also supported the association between MS and LUTS …
The relationship between MS and LUTS was first described by Hammarsten et al. and concluded that men with MS risk factors had …
Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women.
Uzun H, Oğullar S, Ünal H, Zorba OÜ, Yazar S, Kalkan M. Uzun H, et al. Scand J Urol. 2013 Dec;47(6):497-502. doi: 10.3109/21681805.2013.780258. Epub 2013 Mar 26. Scand J Urol. 2013. PMID: 23528112
OBJECTIVE: Metabolic syndrome plays a significant role in the development of benign prostate hyperplasia (BPH) and overactive bladder (OAB). Non-alcoholic fatty liver disease (NAFLD) is accepted as the hepatic component of metabolic …
OBJECTIVE: Metabolic syndrome plays a significant role in the development of benign prostate hyperplasia …
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback